On Wednesday, July 30th, 2026, the Trump administration announced it would release $600 million in funding appropriated by Congress to support Gavi, the Vaccine Alliance, a global immunization program serving children in poor countries. This decision reverses a halt imposed last year by Health and Human Services Secretary Robert F. Kennedy Jr., who stopped U.S. funding over vaccine safety concerns.

According to a State Department press release, the funding resumption followed Gavi's agreement to make "significant commitments that strengthen vaccine safety, improve public health, and better align Gavi’s work with the principles of Gold Standard Science and transparency." These commitments include ceasing the promotion and procurement of COVID-19 vaccines for routine immunization programs and reducing the program’s staffing in Geneva. Additionally, Gavi has allotted the U.S. a seat on its board and will permit American oversight to ensure vaccine safety.

The State Department emphasized, "President Trump has made clear that American leadership in global health must be rooted in accountability, scientific excellence, and measurable results."

Gavi’s head executive, Sania Nishtar, expressed gratitude for the renewed support, stating, "This investment will help us to strengthen global defenses against outbreaks and pandemics and protect more children from preventable diseases. The United States’ partnership has been a key contributor to Gavi’s success in immunizing over 1.2 billion children since 2000 and we look forward to renewing this partnership and achieving even greater impact in the years ahead."

Meanwhile, Kennedy accused the Biden administration of allowing "glaringly racist policies" that enabled the vaccine alliance to "inject more than 72 million African and Asian children with cheap jabs containing bolus doses of the world’s most potent neurotoxin."